L. Nieminen

Resectability, conversion, metastasectomy and outcome according to RAS and BRAF status for metastatic colorectal cancer in the prospective RAXO study

J. Kononen, T. Kuopio, A. Ristimäki, 2022, British Journal of Cancer.

Immunohistochemical somatostatin receptor expression in insulinomas

M. Rönty, M. Söderström, J. Arola, 2023 .

An easily adaptable validated risk score predicts cancer-specific survival in stage II colon cancer

H. Minn, O. Carpén, H. Huhtinen, 2020, Acta oncologica.

Resectability and resection rates of colorectal liver metastases according to RAS and BRAF mutational status: prospective study

J. Kononen, T. Kuopio, A. Ristimäki, 2022, The British journal of surgery.

Atypical (non‐V600E) BRAF mutations in metastatic colorectal cancer in population and real‐world cohorts

T. Sjöblom, T. Kuopio, H. Sorbye, 2023, International journal of cancer.

Impact of Primary Tumor Location on Demographics, Resectability, Outcomes, and Quality of Life in Finnish Metastatic Colorectal Cancer Patients (Subgroup Analysis of the RAXO Study)

J. Sundström, T. Salminen, R. Ristamäki, 2024, Cancers.